Survival gain in glioblastoma patients treated with dendritic cell immunotherapy is associated with increased NK but not CD8+ T cell activation in the presence of adjuvant temozolomide
Published 2018 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Survival gain in glioblastoma patients treated with dendritic cell immunotherapy is associated with increased NK but not CD8+ T cell activation in the presence of adjuvant temozolomide
Authors
Keywords
-
Journal
OncoImmunology
Volume 7, Issue 4, Pages e1412901
Publisher
Informa UK Limited
Online
2017-12-08
DOI
10.1080/2162402x.2017.1412901
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Prolonged contact with dendritic cells turns lymph node‐resident NK cells into anti‐tumor effectors
- (2016) Francesca Mingozzi et al. EMBO Molecular Medicine
- NK Cells Restrain Spontaneous Antitumor CD8+T Cell Priming through PD-1/PD-L1 Interactions with Dendritic Cells
- (2016) Ximena L. Raffo Iraolagoitia et al. JOURNAL OF IMMUNOLOGY
- Role of the Drug Transporter ABCC3 in Breast Cancer Chemoresistance
- (2016) Sai A. Balaji et al. PLoS One
- Safe and Reproducible Preparation of Functional Dendritic Cells for Immunotherapy in Glioblastoma Patients
- (2015) Sara Nava et al. Stem Cells Translational Medicine
- Metronomic cyclophosphamide eradicates large implanted GL261 gliomas by activating antitumor Cd8+T-cell responses and immune memory
- (2015) Junjie Wu et al. OncoImmunology
- The multidrug-resistance transporter Abcc3 protects NK cells from chemotherapy in a murine model of malignant glioma
- (2015) Sara Pessina et al. OncoImmunology
- Perspectives for immunotherapy in glioblastoma treatment
- (2014) Gaetano Finocchiaro et al. CURRENT OPINION IN ONCOLOGY
- NK Cells Are Required for Dendritic Cell-Based Immunotherapy at the Time of Tumor Challenge
- (2014) A. L. Bouwer et al. JOURNAL OF IMMUNOLOGY
- Clinical use of dendritic cells for cancer therapy
- (2014) Sébastien Anguille et al. LANCET ONCOLOGY
- Intratumoral temozolomide synergizes with immunotherapy in a T cell-dependent fashion
- (2013) Sara Fritzell et al. CANCER IMMUNOLOGY IMMUNOTHERAPY
- IL-18-Primed Helper NK Cells Collaborate with Dendritic Cells to Promote Recruitment of Effector CD8+ T Cells to the Tumor Microenvironment
- (2013) J. L. Wong et al. CANCER RESEARCH
- Profound Impairment of Adaptive Immune Responses by Alkylating Chemotherapy
- (2013) A. J. Litterman et al. JOURNAL OF IMMUNOLOGY
- ABCC3 as a marker for multidrug resistance in non-small cell lung cancer
- (2013) Yanbin Zhao et al. Scientific Reports
- The natural killer cell response and tumor debulking are associated with prolonged survival in recurrent glioblastoma patients receiving dendritic cells loaded with autologous tumor lysates
- (2013) Serena Pellegatta et al. OncoImmunology
- The secret ally: immunostimulation by anticancer drugs
- (2012) Lorenzo Galluzzi et al. NATURE REVIEWS DRUG DISCOVERY
- An Optimized Method for Manufacturing a Clinical Scale Dendritic Cell-Based Vaccine for the Treatment of Glioblastoma
- (2012) Sara Nava et al. PLoS One
- Cancer immunotherapy – revisited
- (2011) W. Joost Lesterhuis et al. NATURE REVIEWS DRUG DISCOVERY
- Phase II Trial of Continuous Dose-Intense Temozolomide in Recurrent Malignant Glioma: RESCUE Study
- (2010) James R. Perry et al. JOURNAL OF CLINICAL ONCOLOGY
- Updated Response Assessment Criteria for High-Grade Gliomas: Response Assessment in Neuro-Oncology Working Group
- (2010) Patrick Y. Wen et al. JOURNAL OF CLINICAL ONCOLOGY
- Greater chemotherapy-induced lymphopenia enhances tumor-specific immune responses that eliminate EGFRvIII-expressing tumor cells in patients with glioblastoma
- (2010) J. H. Sampson et al. NEURO-ONCOLOGY
- Treg depletion with a low-dose metronomic temozolomide regimen in a rat glioma model
- (2009) Claire Banissi et al. CANCER IMMUNOLOGY IMMUNOTHERAPY
- Immunological Factors Relating to the Antitumor Effect of Temozolomide Chemoimmunotherapy in a Murine Glioma Model
- (2009) T.-G. Kim et al. Clinical and Vaccine Immunology
- Nomograms for predicting survival of patients with newly diagnosed glioblastoma: prognostic factor analysis of EORTC and NCIC trial 26981-22981/CE.3
- (2007) Thierry Gorlia et al. LANCET ONCOLOGY
- Immunological responses in a patient with glioblastoma multiforme treated with sequential courses of temozolomide and immunotherapy: Case study
- (2007) Amy B. Heimberger et al. NEURO-ONCOLOGY
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now